Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"What is conceivably being argued against advancing Brilacidin?"

Maybe a lack of any independent verification or scientific discussion of the covid-related results? It's probably not good enough to have them described as "(OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, reports today receiving additional data from a U.S. Regional Biocontainment Laboratory (RBL)".

Where's that pre-print? That might adequately address the issue.


ps. This is certainly true: “Oh it’s only in early stage clinicals, Rem was much further ahead”.
In fact the appropriate dosage of B for covid hasn't been mentioned, has it?